Table 1.
Patient characteristics and PET information
| Nr. | Age at diagnosis (years) | Weight (kg) | Histology | Stage | MTV (cm3) | Hypoxia in [18F]EF5 PET/CT | Hypoxic subvolume (cm3, % of MTV) | Injected [18F]EF5 activity (Mbq) |
|---|---|---|---|---|---|---|---|---|
| 1 | 62 | 106 | high grade serous | IIIC | 571 | yes | 364 (64%) | 381 |
| 2 | 56 | 81 | endometrioid | IIB | 250 | yes | 121 (49%) | 367 |
| 3 | 65 | 100 | sarcoma | IIB | 1908 | yes | 42 (2%) | 374 |
| 4 | 38 | 93 | mucinous | IA | 158 | no | 367 | |
| 5 | 73 | 54 | carcinosarcoma | IIIC | 267 | yes | 17 (6%) | 301 |
| 6 | 79 | 68 | high grade serous | IVB | 615 | yes | 202 (33%) | 220 |
| 7 | 67 | 63 | high grade serous | IIIC | 955 | no | 385 | |
| 8 | 56 | 70 | fibroma | - | 224 | no | 377 | |
| 9 | 50 | 103 | clear cell | IIIC | 116 | no | 378 | |
| 10 | 69 | 77 | high grade serous | IVA | 324 | no | 380 | |
| 11 | 45 | 91 | serous BOT | IA | 66 | no | 374 | |
| 12 | 65 | 69 | high grade serous | IIIC | 273 | no | 377 | |
| 13 | 50 | 152 | endometrioid | IIA | 173 | no | 363 | |
| 14 | 68 | 59 | high grade serous | IIIC | 1288 | yes | 87 (7%) | 362 |
| 15 | 64 | 60 | endometrioid | IIA | 346 | yes | 33 (10%) | 177 |
BOT borderline ovarian tumor, MTV metabolic tumor volume, HSV hypoxic subvolume